Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.38 EUR | -5.10% | -11.51% | -0.37% |
Jun. 14 | Countries want natural hazard insurance and insist on: Speed | DP |
Jun. 14 | Federal states urge federal government to introduce compulsory natural hazard insurance | DP |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.73 for the current period. Therefore, the company is undervalued.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.37% | 69.29B | - | ||
+5.50% | 49.46B | B | ||
+3.66% | 48.75B | B+ | ||
+17.83% | 44.91B | B+ | ||
+9.06% | 40.62B | B+ | ||
+20.40% | 34.09B | B | ||
-4.92% | 27.56B | B | ||
-10.60% | 26.6B | B- | ||
+27.21% | 26.35B | A | ||
-21.10% | 24.32B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CS Stock
- AXA Stock
- Ratings AXA